- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: rituximab, cyclophosphamide, reduced dose of doxorubicin, vincristine, and prednisone
Total 1974 results
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruiting
-
Institut BergoniéNational Cancer Institute, FranceCompleted
-
University of Southern CaliforniaOrtho Biotech, Inc.CompletedNon-Hodgkin's LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingLymphoma, Large B-Cell, Diffuse | Lymphoma, AIDS-relatedUnited States
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaItaly, United Kingdom, Belgium, Brazil, Denmark, France, Peru, Colombia, Canada, Georgia, Singapore, Spain, Thailand, Australia, Germany, Mexico, Russian Federation, South Africa, Finland, Bosnia and Herzegovina, Bulgaria, Croatia, ... and more
-
Hebei Medical University Fourth HospitalUnknownDiffuse Large B-cell LymphomaChina
-
University of GiessenCompletedMarginal Zone Lymphomas | Non-Hodgkin Lymphomas | Follicular Lymphomas | Immunocytomas | Lymphocytic LymphomasGermany
-
University of SouthamptonTerminated
-
University of ChicagoMerck Sharp & Dohme LLCRecruitingLymphoma | Lymphoma, B-Cell | B Cell Lymphoma | Diffuse Large B Cell Lymphoma | High-grade B-cell LymphomaUnited States
-
Genentech, Inc.Completed
-
National Cancer Institute (NCI)RecruitingLymphoplasmacytic Lymphoma | Ann Arbor Stage III Diffuse Large B-Cell Lymphoma | Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Grade 3b Follicular... and other conditionsUnited States
-
Children's Cancer Group, ChinaXiangya Hospital of Central South University; Qilu Hospital of Shandong University and other collaboratorsActive, not recruiting
-
National Cancer Institute (NCI)Active, not recruitingAnn Arbor Stage III Non-Hodgkin Lymphoma | Ann Arbor Stage IV Non-Hodgkin Lymphoma | Ann Arbor Stage II Non-Hodgkin LymphomaUnited States
-
GenmabAbbVieRecruitingSmall Lymphocytic Lymphoma | Richter's Syndrome | Relapsed/Refractory Chronic Lymphocytic LeukemiaUnited States, Belgium, Netherlands, Spain, Italy, Australia, Israel, France, Denmark, Czechia, Germany, United Kingdom
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Completed
-
Southwest Oncology GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology Group; NCIC Clinical... and other collaboratorsCompleted
-
NCIC Clinical Trials GroupCompleted
-
Sun Yat-sen UniversityFudan University; Antengene CorporationRecruitingEBV-Positive Diffuse Large B-Cell Lymphoma, NosChina
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedNon-Hodgkin's Lymphoma | Mantle Cell LymphomaUnited States, Australia, Brazil, Canada, Mexico, New Zealand, Peru
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Acrotech Biopharma Inc.RecruitingPeripheral T Cell LymphomaUnited States
-
Sun Yat-sen UniversityNot yet recruiting
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
Trans Tasman Radiation Oncology GroupAustralasian Leukaemia and Lymphoma Group; Australasian Radiation Oncology... and other collaboratorsCompleted
-
National Cancer Institute (NCI)CompletedMantle Cell Lymphoma | Lymphoma, Mantle CellUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisChildren's Oncology GroupActive, not recruitingPrimary Mediastinal Large B Cell LymphomaFrance, Belgium, United Kingdom, Netherlands, Canada, Hungary, Italy, Poland, Spain
-
Shanghai CP Guojian Pharmaceutical Co., Ltd.CompletedDiffuse Large B Cell LymphomaChina
-
Genentech, Inc.Completed
-
French Innovative Leukemia OrganisationTerminated
-
National Cancer Institute (NCI)CompletedDiffuse Large B-Cell Lymphoma | Hodgkin LymphomaUnited States
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.TerminatedPeripheral T Cell Lymphoma | Treatment-naïveChina
-
Nanfang Hospital of Southern Medical UniversityUnknownPeripheral T Cell LymphomaChina
-
Yale UniversityKyowa Kirin, Inc.Not yet recruitingT Cell LymphomaUnited States
-
Yazeed SawalhaRecruitingZanubrutinib in Combination With R-CHOP (ZaR-CHOP) for Newly Diagnosed Diffuse Large B-Cell LymphomaDiffuse Large B-Cell Lymphoma | Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma | Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell LymphomaUnited States
-
Novartis PharmaceuticalsRecruitingFollicular Lymphoma (FL)Australia, Korea, Republic of, Spain, Singapore, Poland, Taiwan, Hungary, Czechia, Romania, Slovakia
-
Gustave Roussy, Cancer Campus, Grand ParisChildren's Oncology GroupUnknownB-cell Non Hodgkin Lymphoma | Mature B-cell Leukemia Burkitt-typeBelgium, France, United Kingdom, Netherlands, Canada, Hungary, Italy, Poland, Spain, China
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia | Recurrent Burkitt Lymphoma | AIDS-Related Burkitt Lymphoma | Atypical Burkitt/Burkitt-Like Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | High Grade B-Cell Lymphoma With MYC, BCL2... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingAnn Arbor Stage II Diffuse Large B-Cell Lymphoma | Ann Arbor Stage III Diffuse Large B-Cell Lymphoma | Ann Arbor Stage IV Diffuse Large B-Cell LymphomaUnited States
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedMantle Cell LymphomaChina, Belgium, Thailand, United States, Spain, Canada, Colombia, Italy, Morocco, Brazil, Turkey, Chile, Malaysia, Israel, Portugal, Singapore, Russian Federation, Philippines, Tunisia, Austria, Czechia, Germany, Hungary, India, Poland, R... and more
-
German High-Grade Non-Hodgkin's Lymphoma Study...CompletedLymphomaGermany, Switzerland
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Millennium Pharmaceuticals, Inc.CompletedRelapsed Follicular LymphomaUnited States, Puerto Rico
-
Konkuk University Medical CenterSeoul St. Mary's HospitalCompletedLymphomaKorea, Republic of
-
GenmabAbbVieActive, not recruitingFollicular Lymphoma | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Small Lymphocytic Lymphoma | High-grade B-cell Lymphoma | Primary Mediastinal Large B Cell LymphomaJapan
-
Christine Mauz-KörholzMartin-Luther-Universität Halle-WittenbergCompletedLymphomaGermany, Switzerland
-
Christine Mauz-KörholzCompleted
-
Wenqi JiangUnknownR-CHOP Versus R-CDOP as First-line Treatment for Elderly Patients With Diffuse Large-B-cell LymphomaLymphoma, Large B-Cell, DiffuseChina
-
Joseph TuscanoNational Cancer Institute (NCI); ADC Therapeutics S.A.RecruitingHigh Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Double-Expressor Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 RearrangementsUnited States
-
Fox Chase Cancer CenterGenentech, Inc.WithdrawnStage III Adult Diffuse Large Cell Lymphoma | Stage IV Adult Diffuse Large Cell Lymphoma | Contiguous Stage II Adult Diffuse Large Cell Lymphoma | Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma | Stage I Adult Diffuse Large Cell LymphomaUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed